LyondellBasell (LYB)
NYSE: LYB · Specialty Chemicals · Houston, TX
Our rating: Cautious
Cautious reaffirmed at $60.72, moderate conviction, November 6, 2026.
Breaks if: The cautious view proves wrong if LYB reports trailing-twelve-month free cash flow above $1.5B in either of the next two quarterly filings, confirming the gap between accounting income and actual cash has begun to close as the cycle turns. On price, a move above $78 — roughly 28% above today's level — sustained for 63 trading days would signal the market is pricing in a recovery not yet visible in the reported figures, and the call would need to be revisited.
Key figures
| Market value | $18.0B |
|---|---|
| Revenue, last 12 months | $32.0B |
| Net income, last 12 months | $1.3B |
| Free cash flow, last 12 months | $2.4B |
| Price to earnings | 13.9× |
| Free cash flow yield | 13.4% |
| Dividend yield | 6.2% |
| Operating margin | 8.6% |
| Return on equity | 11.9% |
| Beta to the S&P 500 | 0.61 |
| Volatility, annualized | 38.4% |
Reported quarters
| Quarter ending | Revenue | Year on year | Earnings per share | Free cash flow |
|---|---|---|---|---|
| September 30, 2026 | $8.5B | 10.0% | $2.32 | $1.4B |
| June 30, 2026 | $9.2B | 19.8% | $1.71 | $482M |
| March 31, 2026 | $7.2B | −6.3% | $0.38 | −$538M |
| December 31, 2025 | $7.1B | −9.2% | $-0.45 | $1.1B |
| September 30, 2025 | $7.7B | −10.2% | $-2.77 | $577M |
| June 30, 2025 | $7.7B | −11.8% | $0.34 | −$188M |
| March 31, 2025 | $7.7B | −7.6% | $0.54 | −$1.1B |
| December 31, 2024 | $7.8B | 261.8% | $-1.85 | $1.4B |
Three-model forecasts for the next quarter
Written November 21, 2026, before the report. Each settles from the SEC filing.
- Revenue for the quarter is at least $7.35B: Claude 62%, Gemini 90%, Mistral 82%
- Diluted earnings per share are above zero: Claude 68%, Gemini 95%, Mistral 85%
- Free cash flow for the quarter is at least $1.06B: Claude 42%, Gemini 80%, Mistral 62%
15 ledger entries and 52 corporate events on record. Share price as of November 20, 2026. Research and education only. Not investment advice. Stoquity does not manage money or know your circumstances. Ratings, forecasts and lists are produced by software and AI models and can be wrong. Performance figures are hypothetical, measured on paper against a benchmark, and say nothing certain about the future.